Skip to main content
Gel-e's internal bleeding control device nabs breakthrough status
6/19/2019

The FDA has granted wound care startup Gel-e breakthrough status designation for its Life Foam expanding, injectable hemostat. The internal-use flowable device is intended for rapidly providing temporary bleeding control in patients with non-compressible abdominal wounds not suited for tourniquet use in battlefield and trauma conditions.

Full Story: